Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -466.08
- Piotroski Score 2.00
- Grade Hold
- Symbol (ZIVO)
- Company ZIVO Bioscience, Inc.
- Price $21.00
- Changes Percentage (0%)
- Change -$0
- Day Low $20.90
- Day High $21.00
- Year High $22.15
ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. It operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is based in Bloomfield Hills, Michigan.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/14/2024
- Fiscal Year End N/A
- Average Stock Price Target $12.00
- High Stock Price Target $12.00
- Low Stock Price Target $12.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$3.81
- Trailing P/E Ratio -1.96
- Forward P/E Ratio -1.96
- P/E Growth -1.96
- Net Income $-7,777,184
Income Statement
Quarterly
Annual
Latest News of ZIVO
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Director and 10% Owner Christopher Maggiore Acquires 31,336 Shares of Zivo Bioscience Inc (ZIVO)
On August 22, 2024, Christopher Maggiore, Director and 10% Owner of Zivo Bioscience Inc, bought 31,336 shares at $8.34 each, totaling about $261,043.44....
By Yahoo! Finance | 2 months ago
